For-profit hospital outlook improves to stable, according to Moody’s
Moody’s shifted its outlook for for-profit hospitals from negative to neutral in response to ongoing federal assistance and an expected volume recovery.
Stark, Anti-Kickback changes draw praise from providers
Final rules modifying enforcement of the Stark Law and the Anti-Kickback Statute aim to remove barriers to participation in value-based payment models.
Telehealth: Moving from stop-gap measures to an integrated care delivery model
With telemedicine on the rise, two senior leaders advise having proper denials prevention and response strategy, along with ideas on motivating physicians to participate in telehealth programs.
News briefs: December-January 2020-21: Recent trends shaping healthcare finance
Read about the key factors that have shaped healthcare finance policy and practice.
Lessons learned from the transition from volume to value
To effectively transition to value, ACO must fully grasp the success factors that will determine future success under value-based payment, including success with downside risk. A research study examined key organizational, financial, market and other characteristics that support the decision to take on risk.
Hospitals and health systems remain optimistic, overall, about APMs
An August HFMA survey, sponsored by GHX, found that, overall, hospitals and health systems are optimistic about seeing improvements in coordination and collaboration with partners in risk-based payment models over the next five years. The findings suggest organizations are moving ahead unabated in their value-based payment strategies.
HHS Provider Relief Fund clarifications provide much-needed information
Several clarifications related to the treatment of depreciation, expenses for stockpiling PPE and revenue to the HHS Provider Relief Fund (PRF) FAQs were released Nov. 18 by the U.S. Department of Health & Human Services.
CMMI releases interim final rule detailing the payment model for separately payable Part B drugs
HFMA's Chad Mulvany says it is likely drug manufacturers will sue to stop the rule, and they may have several strong legal arguments that would at least delay, if not overturn the rule.
Financial Sustainability Report: October 2020
The October 2020 Financial Sustainability Report, sponsored by Kaufman Hall, explores aspects of healthcare’s transition to value-based payment, including how to pursue a value-based approach to maternity care, and how the transitional approaches differ among hospitals and health systems based on each organization’s unique circumstances.
Financial Sustainability Report: September 2020
The September 2020 Financial Sustainability Report, sponsored by Kaufman Hall, explores looming imperatives and opportunities for healthcare providers, including the Medicare Direct Contracting APM and the price transparency rule, with guidance on steps to prepare.